Cipla press releases

The latest press releases from Cipla (BSE: 500087), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Cipla release within minutes of publication.

Listing: BSE: 500087
Latest release: Sep 3, 2026
On this page: 2 newest releases

Latest Cipla press releases

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the USSep 3, 2026
MUMBAI, India and WARREN, N.J., Sept. 3, 2026 /PRNewswire/ -- Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited (BSE: 500087) (NSE: CIPLA) today announced that it has entered int…
Cipla Receives U.S. FDA Approval for Generic Advair Diskus®Jul 28, 2026
(Fluticasone Propionate and Salmeterol Inhalation Powder), across all three strengths MUMBAI, India and WARREN, N.J., July 28, 2026 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and here…

PPN World is independent and not affiliated with Cipla. Headlines and short excerpts only; each release links to its source.

Questions

Where can I find Cipla press releases?+

On this page: the newest Cipla releases, newest first, each linking to the full text at its source. Cipla also publishes them on its own website and, as a listed company, through the newswires investors follow.

How do I get an alert when Cipla publishes a press release?+

Create a free PPN World account and add Cipla to your watchlist. You get an email the moment a new Cipla release reaches the wire, and every release on this page unlocks.

Is this Cipla's official newsroom?+

No. PPN World is an independent press release monitor and is not affiliated with Cipla. We list the headline, date and a short excerpt of each release and link to the original publication for the full text.

Know the minute Cipla publishes

Watch Cipla, its competitors and its sector in one live feed, with email alerts — on the free plan.

Create free account Talk to our team